- Home
- INLX vs CNTB Comparison
INLX vs CNTB Comparison
Compare INLX & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INLX
- CNTB
- Stock Information
- Founded
- INLX 1996
- CNTB 2012
- Country
- INLX United States
- CNTB United States
- Employees
- INLX 199
- CNTB N/A
- Industry
- INLX EDP Services
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- INLX Technology
- CNTB Health Care
- Exchange
- INLX Nasdaq
- CNTB Nasdaq
- Market Cap
- INLX 59.0M
- CNTB 65.5M
- IPO Year
- INLX N/A
- CNTB 2021
- Fundamental
- Price
- INLX $14.10
- CNTB $1.06
- Analyst Decision
- INLX
- CNTB Strong Buy
- Analyst Count
- INLX 0
- CNTB 1
- Target Price
- INLX N/A
- CNTB $8.00
- AVG Volume (30 Days)
- INLX 4.3K
- CNTB 31.2K
- Earning Date
- INLX 11-13-2024
- CNTB 09-05-2024
- Dividend Yield
- INLX N/A
- CNTB N/A
- EPS Growth
- INLX N/A
- CNTB N/A
- EPS
- INLX N/A
- CNTB N/A
- Revenue
- INLX $17,930,991.00
- CNTB $24,116,000.00
- Revenue This Year
- INLX $9.27
- CNTB N/A
- Revenue Next Year
- INLX $8.10
- CNTB $63.90
- P/E Ratio
- INLX N/A
- CNTB N/A
- Revenue Growth
- INLX 7.17
- CNTB N/A
- 52 Week Low
- INLX $4.52
- CNTB $0.77
- 52 Week High
- INLX $16.50
- CNTB $2.66
- Technical
- Relative Strength Index (RSI)
- INLX 49.53
- CNTB 46.58
- Support Level
- INLX $13.49
- CNTB $1.04
- Resistance Level
- INLX $14.38
- CNTB $1.23
- Average True Range (ATR)
- INLX 0.57
- CNTB 0.10
- MACD
- INLX -0.07
- CNTB 0.01
- Stochastic Oscillator
- INLX 47.96
- CNTB 42.37
About INLX Intellinetics Inc.
Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document strategy to convert documents from one medium to another.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.